Add Yahoo as a preferred source to see more of our stories on Google. Health Canada says the Grifols plasma site on Taylor Avenue will be subject to a set of new conditions, but another on Innovation ...
Yahoo News UK: Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Manitoba deaths
Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Manitoba deaths
Spanish drugmaker Grifols SA is facing restrictions on its Canadian licence to collect blood products following the deaths of two patients who made plasma donations in the country. Health Canada, the ...
Yahoo News Canada: Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Winnipeg deaths
Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Winnipeg deaths
manilatimes: Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates
Ban Grifols and return plasma collection to Canadian Blood Services and Héma-Québec, say health care advocates
MSN: Health Canada slaps new conditions on plasma donation company Grifols, still reviewing 2 Winnipeg deaths
Yahoo: 2 deaths after giving plasma in Winnipeg not linked to donation process: Health Canada
2 deaths after giving plasma in Winnipeg not linked to donation process: Health Canada
The Hamilton Spectator: Health Canada curbs paid plasma clinics after donor deaths: What it means for Hamilton
Health Canada said on April 1 that it added new terms and conditions to the licences of all 16 Grifols clinics in the country “due to recurring, systemic deficiencies across several sites.” Joanna ...
Health Canada curbs paid plasma clinics after donor deaths: What it means for Hamilton
Nickel Belt MPP France Gélinas says Health Canada has found ‘serious infractions’ with the way the plasma collection firm operates ...
Add Yahoo as a preferred source to see more of our stories on Google. Health Canada says an inspection of Grifols's Canadian head office in Ontario found the company wasn't accurately assessing a ...
The Globe and Mail: Government probes into the deaths of two plasma donors found no link to Grifols’ donation process
Government probes into the deaths of two plasma donors found no link to Grifols’ donation process
MarketWatch: Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance
Health Coalition demands disclosures & end to Grifols' for-profit blood plasma contract following reports of deaths, harm, non-compliance
Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
Grifols is also a leader in transfusion medicine, helping ensure the safety of the world’s blood supply. In addition, we provide biological materials, including plasma, for life-science research and further manufacturing, and the company has a comprehensive portfolio of tools, information and services that enable hospitals to efficiently ...
Calgary Herald: Grifols plasma collection site in Calgary slapped with regulatory non-compliance ratings
OTTAWA, (GLOBE NEWSWIRE)-- Proponents of public universal health care across Canada are calling for the closure of Grifols facilities in the wake of two deaths in Winnipeg of people who ...
Health Canada has slapped new terms and conditions on all of a company's paid plasma centres after multiple failed inspections where the regulator found "recurring, systemic deficiencies." This comes ...
Yahoo News Canada: 2 deaths after giving plasma in Winnipeg not linked to donation process: Health Canada
MSN: How much money can you get for donating plasma? Here’s what experts say
How much money can you get for donating plasma? Here’s what experts say
Spanish plasma-derived medicines company Grifols announced that it has successfully completed the refinancing of its 2027 debt maturities through a new credit agreement structured as a Term Loan B ...
Seeking Alpha: Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
The addition of the Clayton site in 2011 marked a new milestone for Grifols (GRFS), turning the company into a top-three plasma industry leader and setting the stage for sustained business growth The ...
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
Spanish drugmaker Grifols SA paid a higher price to buy blood plasma from an entity linked to its controlling family than from third-party suppliers, according to a regulator’s findings submitted in a ...
MSN: Grifols, S.A. (GRFS) to Double Plasma Production With New Spain Facility
MADRID, Sept 20 (Reuters) - Three investment funds with holdings in Spanish drugmaker Grifols (GRLS.MC), opens new tab have teamed up to ask to fill a vacant seat on the company's board, they said in ...
ascopubs.org: Changes in plasma metabolomic profiles during the first 3 months of androgen-deprivation therapy for prostate cancer.
Changes in plasma metabolomic profiles during the first 3 months of androgen-deprivation therapy for prostate cancer.
ascopubs.org: Use of plasma metabolomic profile to predict breast cancer survival: Risk stratification based on tumor nutrient dependencies.
Use of plasma metabolomic profile to predict breast cancer survival: Risk stratification based on tumor nutrient dependencies.
How can I fix the error "DOM text is reinterpreted as HTML without ...
Advocate calls for formal inquiry into company’s operations, citing concerns over Health Canada’s investigation of the deaths ...
Grifols is a global healthcare company that has enhanced the health and well-being of people around the world.
Explore Grifols Poland, a leader in biotechnology and healthcare, dedicated to improving patient lives through innovative therapies and high-quality services.
Descubre las innovadoras soluciones biofarmacéuticas y sanitarias integrales de Grifols centradas en el paciente.
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the first analysis laboratory in Barcelona: Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos.
Join Grifols to create a lasting impact with your career. Explore opportunities that allow you to contribute to life-saving solutions and innovate for a healthier future.
Contact Grifols for inquiries and support. Our team is here to assist you with information and resources tailored to your needs.